These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10742985)

  • 1. Organic anion transporters.
    Tsuji A; Tamai I
    Pharm Biotechnol; 1999; 12():471-91. PubMed ID: 10742985
    [No Abstract]   [Full Text] [Related]  

  • 2. Transporters for bile acids and organic anions.
    Suzuki H; Sugiyama Y
    Pharm Biotechnol; 1999; 12():387-439. PubMed ID: 10742983
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug transporters in pharmacokinetics.
    Petzinger E; Geyer J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of drug transporters at the blood-brain barrier.
    Fricker G; Miller DS
    Pharmacology; 2004 Apr; 70(4):169-76. PubMed ID: 15001817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.
    Kusuhara H; Sugiyama Y
    Drug Metab Pharmacokinet; 2009; 24(1):37-52. PubMed ID: 19252335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug disposition and targeting. Transport across the blood-brain barrier.
    Rochat B; Audus KL
    Pharm Biotechnol; 1999; 12():181-200. PubMed ID: 10742975
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug transport in intestine, liver and kidney.
    Schwenk M
    Arch Toxicol; 1987; 60(1-3):37-42. PubMed ID: 3304216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs.
    Kusuhara H; Suzuki H; Sugiyama Y
    J Pharm Sci; 1998 Sep; 87(9):1025-40. PubMed ID: 9724551
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates.
    Sahi J
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):409-27. PubMed ID: 16863453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids, transporters and the blood--brain barrier.
    Sweeney BP; Grayling M
    Eur J Anaesthesiol; 2005 Jul; 22(7):489-91. PubMed ID: 16045135
    [No Abstract]   [Full Text] [Related]  

  • 11. Organic Anion Transporter 2: An Enigmatic Human Solute Carrier.
    Shen H; Lai Y; Rodrigues AD
    Drug Metab Dispos; 2017 Feb; 45(2):228-236. PubMed ID: 27872146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporters and xenobiotic disposition.
    Kim RB
    Toxicology; 2002 Dec; 181-182():291-7. PubMed ID: 12505328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood-brain barrier transport.
    Yokel RA; Wilson M; Harris WR; Halestrap AP
    Brain Res; 2002 Mar; 930(1-2):101-10. PubMed ID: 11879800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane permeability in the gastrointestinal tract: the interplay between microclimate pH and transporters.
    Kristl A
    Chem Biodivers; 2009 Nov; 6(11):1923-32. PubMed ID: 19937830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of drug transporters at the blood-brain barrier.
    de Boer AG; van der Sandt IC; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2003; 43():629-56. PubMed ID: 12415123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
    Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
    Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid transporters.
    Dawson PA; Oelkers P
    Curr Opin Lipidol; 1995 Apr; 6(2):109-14. PubMed ID: 7773568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active efflux across the blood-brain barrier: role of the solute carrier family.
    Kusuhara H; Sugiyama Y
    NeuroRx; 2005 Jan; 2(1):73-85. PubMed ID: 15717059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of xenobiotic detoxification system mediated by efflux transporters].
    Suzuki H
    Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transporters and renal drug elimination.
    Lee W; Kim RB
    Annu Rev Pharmacol Toxicol; 2004; 44():137-66. PubMed ID: 14744242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.